IS5594A - Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar - Google Patents

Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar

Info

Publication number
IS5594A
IS5594A IS5594A IS5594A IS5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A
Authority
IS
Iceland
Prior art keywords
receptor
angiotensin
pharmaceutical composition
composition containing
receptor agonist
Prior art date
Application number
IS5594A
Other languages
English (en)
Icelandic (is)
Inventor
Fändriks Lars
Petterson Anders
Hallberg Anders
Original Assignee
Pharmacore Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacore Ab filed Critical Pharmacore Ab
Publication of IS5594A publication Critical patent/IS5594A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5594A 1998-02-24 2000-08-21 Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar IS5594A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800550A SE9800550D0 (sv) 1998-02-24 1998-02-24 A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
PCT/SE1999/000262 WO1999043339A1 (en) 1998-02-24 1999-02-24 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof

Publications (1)

Publication Number Publication Date
IS5594A true IS5594A (is) 2000-08-21

Family

ID=20410283

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5594A IS5594A (is) 1998-02-24 2000-08-21 Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar

Country Status (18)

Country Link
EP (1) EP1066048A1 (es)
JP (1) JP2002504516A (es)
KR (1) KR20010041211A (es)
CN (1) CN1291104A (es)
AU (1) AU755949B2 (es)
BR (1) BR9908188A (es)
CA (1) CA2319123A1 (es)
EE (1) EE200000481A (es)
HU (1) HUP0101411A3 (es)
ID (1) ID26639A (es)
IL (1) IL137990A0 (es)
IS (1) IS5594A (es)
MX (1) MXPA00008172A (es)
NO (1) NO20004215L (es)
NZ (1) NZ506188A (es)
SE (1) SE9800550D0 (es)
SK (1) SK11522000A3 (es)
WO (1) WO1999043339A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043761A2 (en) * 1999-12-16 2001-06-21 University Of Southern California Methods for treating and preventing damage to mucosal tissue
US6821953B1 (en) 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
CA2449150C (en) 2001-05-31 2011-07-12 Vicore Pharma Ab Tricyclic compounds useful as angiotensin ii agonists
KR101429484B1 (ko) 2005-04-12 2014-08-13 바이코어 파마 아베 신규한 트리시클릭 안지오텐신 ⅱ 아고니스트
AU2006235706B2 (en) 2005-04-12 2012-03-08 Vicore Pharma Ab New tricyclic angiotensin II agonists
ES2582945T3 (es) 2005-04-12 2016-09-16 Vicore Pharma Ab Nuevos agonistas bicíclicos de angiotensina II
KR101423898B1 (ko) * 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
US8835471B2 (en) 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
US20150119329A1 (en) * 2012-04-16 2015-04-30 New York University Modulation of angiotensin ii receptors for the prevention and treatment of malaria cerebral
AU2016227486A1 (en) 2015-03-02 2017-08-17 Vicore Pharma Ab Angiotensin ll receptor agonist for treating pulmonary fibrosis
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition
WO2021023698A1 (en) 2019-08-02 2021-02-11 Lanthiopep B.V Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer
GB201913603D0 (en) 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
AU2021238939A1 (en) 2020-03-19 2022-11-10 Vicore Pharma Ab Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin II
GB202004094D0 (en) 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202006079D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006081D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202013721D0 (en) 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds
GB202104033D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
US20240182461A1 (en) 2021-03-23 2024-06-06 Vicore Pharma Ab Selective angiotensin ii receptor ligands
GB202104038D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
JP2024523576A (ja) 2021-07-09 2024-06-28 ヴィコール ファルマ アーベー 新規の選択的アンジオテンシンｉｉ化合物
GB202115303D0 (en) 2021-10-25 2021-12-08 Vicore Pharma Ab New formulation
WO2023152503A1 (en) 2022-02-10 2023-08-17 Vicore Pharma Ab Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis
GB202201723D0 (en) 2022-02-10 2022-03-30 Vicore Pharma Ab New use
WO2024133942A1 (en) 2022-12-22 2024-06-27 Vicore Pharma Ab A method of treating a patient diagnosed with an interstitial lung disease
WO2024149712A1 (en) 2023-01-09 2024-07-18 Vicore Pharma Ab Selective angiotensin ii compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444067A (en) * 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
AU3708295A (en) * 1994-11-04 1996-05-31 Stefan L. Marklund Use of receptor agonists to stimulate superoxide dismutase activity
SE9501881D0 (sv) * 1995-05-19 1995-05-19 Astra Ab New pharmacological use of AII-receptor antagonists
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
SE9502219D0 (sv) * 1995-06-19 1995-06-19 Astra Ab Novel medical use

Also Published As

Publication number Publication date
EP1066048A1 (en) 2001-01-10
KR20010041211A (ko) 2001-05-15
HUP0101411A2 (hu) 2002-03-28
AU2753799A (en) 1999-09-15
ID26639A (id) 2001-01-25
SK11522000A3 (sk) 2001-04-09
WO1999043339A1 (en) 1999-09-02
IL137990A0 (en) 2001-10-31
CN1291104A (zh) 2001-04-11
JP2002504516A (ja) 2002-02-12
BR9908188A (pt) 2000-10-24
EE200000481A (et) 2002-02-15
NO20004215L (no) 2000-09-18
HUP0101411A3 (en) 2002-11-28
MXPA00008172A (es) 2002-06-21
CA2319123A1 (en) 1999-09-02
NZ506188A (en) 2003-04-29
NO20004215D0 (no) 2000-08-23
AU755949B2 (en) 2003-01-02
SE9800550D0 (sv) 1998-02-24

Similar Documents

Publication Publication Date Title
IS5594A (is) Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar
HUP0301083A3 (en) Synergistical herbicide composition and use thereof
HUP0201545A2 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
IS5794A (is) Lyfjasamsetning sem inniheldur COX-2-hemil og iNOS-hemil
NO20032753D0 (no) Forbindelse og anvendelse derav
DK0945132T3 (da) Ibuprofen-præparat
HUP0104270A3 (en) Herbicidal composition and use thereof
HUP0003217A3 (en) Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and pharmaceutical compositions containing them
ID27415A (id) Komposisi farmaseutik
EP1112252A4 (en) KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF
NO20006488D0 (no) Sammensetning og anvendelse
ID29262A (id) Komposisi farmasi
IL139865A0 (en) A liver selective glucocorticoid antagonist and pharmaceutical compositions containing the same
NO20010804L (no) Muskariniske agonister og antagonister
NO20004274L (no) Proteaseaktivert reseptor 4 og anvendelse derav
DE69806641D1 (de) Vernetzbare verfilmende zusammensetzung
HUP0402178A3 (en) Pharmaceutical composition comprising a 5 hti receptor agonist
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
ID20466A (id) Komposisi oral
NO20012943D0 (no) Nye heterocykliske forbindelser og farmasöytiske sammensetninger inneholdende det samme
GB9820014D0 (en) Receptor antagonists and uses thereof
BR9710568A (pt) Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2
ID26215A (id) Komposisi farmasi
DE69923065D1 (de) Fluorcopolymer und zusammensetzung daraus